Regulation of Gene Expression by Activation of the Peroxisome Proliferator-Activated Receptor γ with Rosiglitazone (BRL 49653) in Human Adipocytes
- 1 November 1999
- journal article
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 265 (1), 265-271
- https://doi.org/10.1006/bbrc.1999.1657
Abstract
No abstract availableKeywords
This publication has 51 references indexed in Scilit:
- A Unified Nomenclature System for the Nuclear Receptor SuperfamilyCell, 1999
- Thiazolidinediones: a new class of antidiabetic drugsDiabetic Medicine, 1999
- Tissue Distribution and Quantification of the Expression of mRNAs of Peroxisome Proliferator–Activated Receptors and Liver X Receptor-α in Humans: No Alteration in Adipose Tissue of Obese and NIDDM PatientsDiabetes, 1997
- Peroxisome proliferator-activated receptor gene expression in human tissues. Effects of obesity, weight loss, and regulation by insulin and glucocorticoids.Journal of Clinical Investigation, 1997
- Thiazolidinediones in the Treatment of Insulin Resistance and Type II DiabetesDiabetes, 1996
- Thiazolidinediones produce a conformational change in peroxisomal proliferator-activated receptor-gamma: binding and activation correlate with antidiabetic actions in db/db mice.Endocrinology, 1996
- Differential expression of peroxisome proliferator-activated receptors (PPARs): tissue distribution of PPAR-alpha, -beta, and -gamma in the adult rat.Endocrinology, 1996
- The Structure−Activity Relationship between Peroxisome Proliferator-Activated Receptor γ Agonism and the Antihyperglycemic Activity of ThiazolidinedionesJournal of Medicinal Chemistry, 1996
- Metabolic effects of darglitazone, an insulin sensitizer, in NIDDM subjectsDiabetologia, 1995
- An Antidiabetic Thiazolidinedione Is a High Affinity Ligand for Peroxisome Proliferator-activated Receptor γ (PPARγ)Journal of Biological Chemistry, 1995